65 Results for "

Oxytocin receptor

" in MedChemExpress (MCE) Product Catalog:
Products (65)

65 Results for "Oxytocin receptor" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-108677
CAS No.: 160312-62-9
Purity:  99.36%
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

L-368,899 hydrochloride is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively. L-368,899 hydrochloride used as a tocolytic agent .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-17572
CAS No.: 90779-69-4
Synonyms: RW22164; RWJ22164
Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-15023
CAS No.: 900510-03-4
Purity:  99.95%
Synonyms: PF-3274167
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

Cligosiban (PF-3274167) is an orally active, highly selective, and centrally permeable oxytocin receptor antagonist with good pharmacokinetics in rats and can inhibit physiological ejaculation in rodents [1][2].
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-17572A
CAS No.: 914453-95-5
Synonyms: RW22164 acetate; RWJ22164 acetate
Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-17573
CAS No.: 37025-55-1
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease Endocrinology

Carbetocin, an oxytocin (OT) analogue, is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin has high affinity to chimeric N-terminus (E1) of the oxytocin receptor (Ki=1.17 μM). Carbetocin has the potential for postpartum hemorrhage research. Carbetocin can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P3467
CAS No.: 60786-59-6
Research Areas:  

Neurological Disease

(Thr4,Gly7)-Oxytocin, an Oxytocin analogue, is a specific OT receptor agonist. (Thr4,Gly7)-Oxytocin also excites subicular neurons via activation of TRPV1 channels, and depression of K + channels. .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-17573A
CAS No.: 1631754-28-3
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease Endocrinology

Carbetocin acetate, an oxytocin (OT) analogue, is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin acetate has high affinity to chimeric N-terminus (E1) of the oxytocin receptor (Ki=1.17 μM). Carbetocin acetate has the potential for postpartum hemorrhage research. Carbetocin acetate can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15522
CAS No.: 847375-16-0
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease

WAY-267464 is a non-peptide oxytocin receptor (OTR) agonist. WAY-267464 can impair social recognition memory in rats through a vasopressin 1A receptor antagonist action. WAY-267464 can be used for the research of psychiatric disorders, such disorders include autism spectrum disorder, schizophrenia, and social anxiety disorder .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0004
CAS No.: 50-57-7
Synonyms: Lysine vasopressin; [Lys8]-Vasopressin
Lysipressin (Lysine vasopressin ; [Lys8]-Vasopressin ) is a neurohypophyseal nonapeptide with dual cardiovascular regulatory activities of peripheral pressor action and central hypotensive action, and it also regulates pain perception in the body. Lysipressin is an Oxytocin Receptor agonist, with a Ki value of 10.2 nM for porcine OT receptor. Lysipressin stimulates contraction of rabbit bladder smooth muscle via V1-vasopressin receptor. The central hypotensive effect of Lysipressin depends on the sympathetic tone pathway. Lysipressin dose-dependently prolongs tail-flick latency in rats, producing a stable central antinociceptive effect. Lysipressin can be used in studies related to cardiovascular regulation, hypertension and pain .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108679
CAS No.: 1432043-31-6
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease

WAY-267464 (hydrochloride) is a non-peptide oxytocin receptor (OTR) agonist. WAY-267464 (hydrochloride) can impair social recognition memory in rats through a vasopressin 1A receptor antagonist action. WAY-267464 (hydrochloride) can be used for the research of psychiatric disorders, such disorders include autism spectrum disorder, schizophrenia, and social anxiety disorder .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0004A
CAS No.: 83968-49-4
Synonyms: Lysine vasopressin acetate; [Lys8]-Vasopressin acetate
Lysipressin acetate (Lysine vasopressin acetate; [Lys8]-Vasopressin acetate) is a neurohypophyseal nonapeptide with dual cardiovascular regulatory activities of peripheral pressor action and central hypotensive action, and it also regulates pain perception in the body. Lysipressin acetate is an Oxytocin Receptor agonist, with a Ki value of 10.2 nM for porcine OT receptor. Lysipressin acetate stimulates contraction of rabbit bladder smooth muscle via V1-vasopressin receptor. The central hypotensive effect of Lysipressin acetate depends on the sympathetic tone pathway. Lysipressin acetate dose-dependently prolongs tail-flick latency in rats, producing a stable central antinociceptive effect. Lysipressin acetate can be used in studies related to cardiovascular regulation, hypertension and pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P0267
CAS No.: 121062-08-6
Melanotan (MT)-II is a melanocortin receptor agonist. Melanotan (MT)-II activates melanocortin receptor 3 and melanocortin receptor 4, and stimulates the release of central endogenous oxytocin. Melanotan (MT)-II reverses recognition memory impairment, increased anxiety levels and reduced exploratory tendency in zebrafish exposed to short-term high-fat diet. Melanotan (MT)-II improves impaired social behavior indicators in mouse models of autism spectrum disorder. Melanotan (MT)-II induces weight loss, reduces food intake and exerts anorectic effects. Melanotan (MT)-II increases intracavernous pressure and erectile activity in brown rats. Melanotan (MT)-II can be used in studies related to memory impairment, anxiety, reduced exploratory behavior, autism spectrum disorder, obesity and erectile dysfunction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15010
CAS No.: 162042-44-6
Purity:  99.90%
L-371,257 is an orally bioavailable, non-blood-brain barrier penetrant, selective and competitive antagonist of oxytocin receptor (pA2=8.4) with high affinity at both the oxytocin receptor (Ki=19 nM) and vasopressin V1a receptor (Ki=3.7 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W587861
CAS No.: 128-23-4
Synonyms: 5βDHP
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

5β-Dihydroprogesterone (5βDHP) is the metabolite of Progesterone (HY-N0437). 5β-Dihydroprogesterone binds to oxytocin receptor, reduces the Oxytocin (HY-17571)-induced calcium signal transduction, thereby exhibiting the tocolytic activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128351
CAS No.: 2231770-73-1
Purity:  99.69%
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease Endocrinology

SHR1653 is a highly potent, selective and brain penetrated oxytocin receptor (OTR) antagonist, with an IC50 of 15 nM for hOTR .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2626
CAS No.: 61370-87-4
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

[D-Ala2]-Met-Enkephalin, an opioid peptide, is a potent opioid agonist. [D-Ala2]-Met-Enkephalin inhibits ACh-induced and suckling-induced oxytocin (OT) release .
loading...
    loading...
Cat. No.: HY-124733A
CAS No.: 2245072-21-1
Purity:  98.63%
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease

LIT-001 is the first nonpeptide oxytocin receptor (OT-R) agonist (EC50=55 nM; Ki=226 nM). LIT-001 improves social interaction in a mouse model of autism .
loading...
    loading...
Cat. No.: HY-W048739
CAS No.: 312624-65-0
Research Areas:  

Others

Fmoc-α-Me-Leu-OH is a leucine derivative with an Fmoc protecting group, which can be used to synthesize peptides with oxytocin receptor agonist activity .
loading...
    loading...
Cat. No.: HY-14778
CAS No.: 820957-38-8
Purity:  98.97%
Synonyms: GSK 221149; GSK 221149A
Target:  

Oxytocin Receptor

Research Areas:  

Neurological Disease Endocrinology

Retosiban (GSK221149A) is a potent, selective, and orally active oxytocin receptor antagonist (Ki (hOT) = 0.65 nM, Ki (rOT) = 4.1 nM) with no detectable agonist activity. Retosiban has nanomolar affinity for the oxytocin receptor with >1400-fold selectivity over the closely related vasopressin receptors. Retosiban inhibits spontaneous and induces uterine contractions. Retosiban can be studied in research for preterm labour .
loading...
    loading...
Cat. No.: HY-153963
Purity:  99.24%
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

PF-06655075 is a novel andnon–brain-penetrant oxytocin receptor agonist with increased selectivity for the oxytocin receptor and significantly increased pharmacokinetic stability. PF-06655075 can be used as a tool compound to further explore the role of peripheral oxytocin in behavioral response .
loading...
    loading...